Diabetes is a very prevalent disease that, unfortunately, still has no treatment. People with diabetes need to monitor their blood glucose levels (BGLs) regularly and administer insulin to keep them in check. In almost all cases, BGL measurements involve drawing blood from a fingertip through a finger prick. Since this procedure is painful, less invasive alternatives that leverage modern electronics are being actively researched worldwide.
FDA committee recommends AstraZeneca and Sanofi’s RSV prophylactic nirsevimab
Toddler is sick in PICU with RSV and has IV and Oxygen. A US FDA AdComm voted in favour of AstraZeneca’s/Sanofi’snirsevimab. Image Credit: Getty Images
June 9, 2023